CI-911: A placebo-controlled study in patients with primary degenerative dementia

1988 ◽  
Vol 12 (3-4) ◽  
pp. 267-270
Author(s):  
Maurice W. Dysken ◽  
Susan Anton-Johnson ◽  
Linda Klein ◽  
Michael Kuskowski ◽  
Lawrence J. Schut ◽  
...  
1990 ◽  
Vol 3 (1) ◽  
pp. 41-47 ◽  
Author(s):  
Michael A. Kuskowski ◽  
Gerald Morley ◽  
Stephen M. Malone ◽  
Maurice W. Dysken ◽  
Amy Okaya

Changes in smooth pursuit eye movements and the P300 component of the auditory evoked potential were studied in patients with primary degenerative dementia during a double-blind, placebo-controlled study of ergoloid mesylates (Hydergine). After 18 weeks of treatment, P300 latency and amplitude, recorded at three scalp electrode sites, had not changed significantly. Smooth pursuit gain was elevated for the drug group under some stimulus conditions, suggesting a normalization of pursuit eye movement functioning. However, the results of several other measures of the quality of pursuit eye movements failed to corroborate this finding. ( J Geriatr Psychiatry Neurol 1990; 3:41-47).


1981 ◽  
Vol 1 (6) ◽  
pp. 398-400 ◽  
Author(s):  
NUNZIO POMARA ◽  
BARRY REISBERG ◽  
SHARON ALBERS ◽  
STEVEN FERRIS ◽  
SAMUEL GERSHON

1989 ◽  
Vol 23 (3-4) ◽  
pp. 191-199 ◽  
Author(s):  
Gary D. Tollefson ◽  
Michael Godes J. ◽  
Bryan Warren ◽  
Erhard Haus ◽  
Michael Luxenberg ◽  
...  

1994 ◽  
Vol 4 (3) ◽  
pp. 243
Author(s):  
N.R. Cutler ◽  
F.J. Morich ◽  
B. Gulanski ◽  
J. Sramek

Sign in / Sign up

Export Citation Format

Share Document